Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Endocrine

Issue 2-3/2004

Content (22 Articles)

Preface

Glenn R. Cunningham, Tom Lue

Epidemiology of erectile dysfunction

Stanley G. Korenman

Physiology and biochemistry of erections

George J. Christ, Tom Lue

Effect of androgens on penile tissue

Ronald W. Lewis, Thomas M. Mills

Evaluation of the patient with erectile dysfunction

Raymond C. Rosen

Laboratory evaluation of the patient with erectile dysfunction

Sean P. McLaughlin, Culley C. Carsson

Causes of erectile dysfunction

Jeremy P. W. Heaton, Michael A. Adams

Assessment of cardiovascular risk in patients with erectile dysfunction

Robert A. Kloner

Psychotherapy for erectile dysfunction

Stanley E. Althof, Miki Wieder

Therapy of ED

Ridwan Shabsigh

Androgen replacement in men with hypogonadism and erectile dysfunction

Marion Albrecht-Betancourt, Rabih A. Hijazi, Glenn R. Cunningham

Intracavernous pharmacotherapy for erectile dysfunction

Anthony J. Bella, Gerald B. Brock

External devices for treatment of erectile dysfunction

Laurence A. Levine

Surgical management of erectile dysfunction

Aaron J. Milbank, Drogo K. Montague

Therapy of erectile dysfunction

Nestor F. Gonzalez-Cadavid, Jacob Rajfer

Review

The role of TNF-α in insulin resistance

Stephen E. Borst

Clinical Update

Bone and fat

Jeffrey M. Gimble, Mark E. Nuttall

Original Articles

Basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution and in vitro biological-to-immunological ratio in male puberty

A. Olivares, D. Söderlund, C. Castro-Fernández, T. Zariñán, Elena Zambrano, J. P. Méndez, A. Ulloa-Aguirre

Original Articles

Stepwise posttranslational processing of progrowth hormone-releasing hormone (proGHRH) polypeptide by furin and PC1

Samuel F. Posner, Charles A. Vaslet, Michelle Jurofcik, Alisson Lee, Nabil G. Seidah, Eduardo A. Nillni

Original Articles

Effects of raloxifene, one of the selective estrogen receptor modulators, on pituitary-ovary axis and prolactin in postmenopausal women

Wern-Cherng Cheng, Men-Lu Yen, Sandy H. J. Hsu, Kuang-Ho Chen, Keh-Sung Tsai

Original Articles

Estrogen modulates developmentally regulated gene expression in the fetal baboon liver

Miriam D. Rosenthal, Eugene D. Albrecht, Gerald J. Pepe

Retraction Note

Retraction Note to: HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma

Carsten Boltze, Hendrik Lehnert, Regine Schneider-Stock, Brigitte Peters, Cuong Hoang-Vu, Albert Roessner

Feb 04
Issue: 1/2004
Jun 04
Issue: 1/2004

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits